Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma. (Q50211518)
Jump to navigation
Jump to search
scientific article published on 5 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma. |
scientific article published on 5 January 2017 |
Statements
1 reference
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma. (English)
1 reference
Andrew J Cowan
1 reference
Phillip A Stevenson
1 reference
Ted A Gooley
1 reference
Shani L Frayo
1 reference
George R Oliveira
1 reference
Stephen D Smith
1 reference
Damian J Green
1 reference
Jennifer E Roden
1 reference
John M Pagel
1 reference
Brent L Wood
1 reference
5 January 2017
1 reference
1 reference
176
1 reference
583-590
1 reference
4
1 reference
Identifiers
1 reference
1 reference
1 reference